Heterogeneous suppression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B

Clinical and Experimental Metastasis

Volumn 16, Issue 2, 1998, Pages 159-167

  Van Noorden, Cornelis J F ^a,d   Jonges, Trudy G N ^a,e   Van Marle, Jan ^a   Bissell, Eugene R ^b   Griffini, Patrizia ^c   Jans, Miranda ^a   Snel, Jeroen ^a   Smith, Robert E ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Enzyme Systems Products and Prototek   (United States)

^c UNIVERSITY OF PAVIA   (Italy)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e Dept Obstet Gynaecol Acad H   (Netherlands)

Author keywords

Cathepsin B; Fluorescence; Fluorogenic substrate; Liver; Living cell cytochemistry; Metastasis; Protease inhibitors; Rat colon tumor

Indexed keywords

CATHEPSIN B; CYSTEINE PROTEINASE INHIBITOR; MU PHENYLHOMOPHENYLALANYL FLUOROMETHYLKETONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CANCER GROWTH; COLON CARCINOMA; DRUG EFFECT; ENZYME INHIBITION; GROWTH INHIBITION; LIVER METASTASIS; METASTASIS INHIBITION; NONHUMAN; RAT;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; CATHEPSIN B; COLONIC NEOPLASMS; CYSTEINE PROTEINASE INHIBITORS; EXTRACELLULAR SPACE; FEMALE; LIVER; LIVER NEOPLASMS; NEOPLASM METASTASIS; RATS; TUMOR CELLS, CULTURED;

EID: 0031800093     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006524321335     Document Type: Article

References (80)

1. He CS, Wilhelm SM, Pentland AP, et al. 1989, Tissue co-operation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA, 86, 2632-6.
2. Liotta LA, Steeg PS and Stetler-Stevenson WG, 1991, Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-36.
3. Kobayashi H, Moniwa N, Sugimura M, et al. 1993, Effects of membrane-associated cathepsin B on the activation of receptor-bound pro-urokinase and subsequent invasion of reconstituted basement membranes. Biochim Biophys Acta, 1178, 55-62.
4. Ruppert C, Ehrenfordt S, Tutscheck B, et al. 1994, Proteases associated with gynaecological tumours. Int J Oncol, 4, 717-21.
5. Sivaparvathi M, Sawaya R, Wang SW, et al. 1995, Overexpression and localization of cathepsin B during the progression of human gliomas. Clin Exp Metastasis, 13, 49-56.
6. Liotta LA and Stetler-Stevenson WG, 1991, Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res, 51, 5054s-59s.
7. Reich R, Thompson EW, Iwamoto Y, et al. 1988, Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res, 48, 3307-12.
8. Mignatti P and Rifkin DB, 1993, Biology and biochemistry of proteinases in tumor invasion. Physiol Rev, 73, 161-95.
9. Monsky WL, Lin CY, Aoyama A, et al. 1994, A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res, 54, 5702-10.
10. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM and Shafie S, 1980, Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature, 284, 67-8.
11. Emmert-Buck MR, Roth MJ, Zhuang Z, et al. 1994, Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol, 145, 1285-90.
12. Ossowki L and Reich E, 1983, Antibodies to plasminogen activator inhibit human tumor metastasis. Cell, 35, 611-19.
13. Mignatti P, Robbins E and Rifkin DB, 1986, Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell, 47, 487-98.
14. Sier CF, Vloedgraven HJ, Ganesh S, et al. 1994, Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis. Gastroenterology, 107, 1449-56.
15. Sloane BF, Dunn JR and Honn KV, 1981, Lysosomal cathepsin B: correlation with metastatic potential. Science, 212, 1151-3.
16. Sloane BF and Honn KV, 1984, Cysteine proteinases and metastasis. Cancer Metastasis Rev, 3, 249-63.
17. Elliott E and Sloane BF, 1996, The cysteine protease cathepsin B in cancer. Perspect Drug Discov Design, 6, 12-32.
18. Lah TT, Calaf G, Kalman E, et al. 1995, Cathepsins D, B and L in breast carcinoma and in transformed human breast epithelial cells (HBEC). Biol Chem Hoppe-Seyler, 376, 357-63.
19. Scaddan PB and Dufresne MJ, 1993, Characterization of cysteine proteases and their endogenous inhibitors in MCF-7 and adriamycin-resistant MCF-7 human breast cancer cells. Inv Metastasis, 13, 301-13.
20. Maciewicz RA, Wardale RJ, Etherington DJ and Paraskeva C, 1989, Immunodetection of cathepsins B and L present in and secreted from human premalignant and malignant colorectal tumour cell lines. Int J Cancer, 43, 478-86.
21. Qian F, Bajkowski AS, Steiner DF, Chan SJ and Frankfater A, 1989, Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues. Cancer Res, 49, 4870-5.
22. Murnane MJ, Sheahan K, Ozdemirli M and Shuja S, 1991, Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma. Cancer Res, 51, 1137-42.
23. Inoue T, Ishida T, Sugio K and Sugimachi K, 1994, Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma. Cancer Res, 54, 6133-6.
24. Rempel SA, Rosenblum ML, Mikkelsen T, et al. 1994, Cathepsin B expression and localization in glioma progression and invasion. Cancer Res, 54, 6027-31.
25. Campo E, Munoz J, Miquel R, et al. 1994, Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am J Pathol, 145, 301-9.
26. Sheahan K, Shuja S and Murnane MJ, 1989, Cysteine protease activities and tumor development in human colorectal carcinoma. Cancer Res, 49, 3809-14.
27. Everts V, Beertsen W and Tigchelaar-Gutter W, 1985, The digestion of phagocytosed collagen is inhibited by the proteinase inhibitors leupeptin and E-64. Collagen Rel Res, 5, 315-36.
28. 2F suppresses digestion of collagen by libroblasts and osteoclasts. Biochem Biophys Res Commun, 178, 178-84.
29. Sloane BF, Rozhin J, Johnson K, Taylor H, Crissman JD and Honn KV, 1986, Cathepsin B: association with plasma membrane in metastatic tumors. Proc Natl Acad Sci USA, 83, 2483-7.
30. Rozhin J, Sameni M, Ziegler G and Sloane BF, 1994, Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res, 54, 6517-25.
31. Keppler D, Abrahamson M and Sordat B, 1994, Secretion of cathepsin B and tumour invasion. Biochem Soc Trans, 22, 43-9.
32. Reddy VY, Zhang QY and Weiss SJ, 1995, Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad Sci USA, 92, 3849-53.
33. Van Noorden CJF, Vogels IMC and Smith RE, 1989, Localization and cytophotometric analysis of cathepsin B activity in unfixed and undecalcified cryostat sections of whole rat knee joints. J Histochem Cytochem, 37, 617-24.
34. 2F. J Rheumatol, 15, 1525-35.
35. Erdel M, Trefz G, Speass E, et al. 1990, Localization of cathepsin B in two human lung cancer cell lines. J Histochem Cytochem, 38, 1313-21.
36. Spiess E, Bruning A, Gack S, et al. 1994, Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level. J Histochem Cytochem. 42, 917-29.
37. Chan SJ, San Segundo B, McCormick MB and Steiner DF, 1986, Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNAs. Proc Natl Acad Sci USA, 83, 7721-5.
38. Keppler D, Waridel P, Abrahamson M, Bachmann D, Berdox J and Sordat B, 1994, Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase. Biochim Biophys Acta, 1226, 117-25.
39. Basbaum CB and Werb Z, 1996, Focalized proteolysis - spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol, 8, 731-8.
40. Esser RE, Angelo RA, Murphy MD, et al. 1994, Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis. Arth Rheum, 37, 236-47.
41. Harth G, Andrews N, Mills AA, Engel JC, Smith R and McKerrow JH, 1993, Peptide-fluoromethyl ketones arrest intracellular replication and intercellular transmission of Trypanosomacruzi. Mol Biochem Parasitol, 58, 17-24.
42. Calkins CC and Sloane BF, 1995, Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression. Biol Chem Hoppe-Seyler, 376, 71-80.
43. Mort JS and Recklies AD, 1986, Interrelationship of active and latent secreted human cathepsin B precursors. Biochem J, 233, 57-63.
44. Marquet RL, Westbroek DL and Jeekel J, 1984, Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site. Int J Cancer, 33, 689-92.
45. Dingemans KP, van den Bergh Weerman MA, Keep RF and Das PK, 1994, Developmental stages in experimental liver metastases: relation to invasiveness. Int J Cancer, 57, 433-9.
46. Griffini P, Smorenburg SM, Verbeek FJ and Van Noorden CJF, 1997, Three-dimensional reconstruction of colon carcinoma metastases in liver. J Microsc, 187, 12-21.
47. Caro LHP, Plomp PJAM, Wolvetang EJ, Kerkhof C and Meijer AJ, 1988, 3-Methyladenine, an inhibitor of autophagy, has multiple effects on metabolism. Eur J Biochem, 175, 325-9.
48. Van Noorden CJF, Boonacker E, Bissell ER, Meijer A, Van Marle J and Smith RE, 1997, Ala-Pro-cresyl violet, a synthetic fluorogenic substrate for the analysis of kinetic parameters of dipeptidyl peptidase IV (CD26) in individual living rat hepatocyles. Anal Biochem, in press.
49. Jonker A, Geerts WJC, Charles R, Lamers WH and Van Noorden CJF, 1995, Image analysis and image processing as tools to measure initial rates of enzyme reactions in sections: distribution patterns of glutamate dehydrogenase activity in rat liver lobules. J Histochem Cytochem, 43, 1027-34.
50. Wilson RE and Sutherland RM, 1989, Enhanced synthesis of specific proteins, RNA, and DNA caused by hypoxia and reoxygenation. Int J Radiat Oncol, 16, 957-61.
51. Smorenburg SM, Griffini P, Tiggelman A, Moorman AFM, Boers W and Van Noorden CJF, 1996, Alpha2-macroglobulin is mainly produced by cancer cells and not by hepatocytes in rats with colon carcinoma metastases in liver. Hepatology, 23, 560-70.
52. Griffini P, Smorenburg SM, Vogels IMC, Tigchelaar W and Van Noorden CJF, 1996, Kupffer cells and pit cells are not effective in the defense against experimentally induced colon carcinoma metastasis in rat liver. Clin Exp Metastasis, 14, 367-80.
53. Ahmed NK, Martin LA, Watts LM, et al. 1993, Peptidyl fluoromethyl ketones as inhibitors of cathepsin B. Biochem Pharmacol, 44, 1201-7.
54. Van Noorden CJF and Frederiks W, 1992, Enzyme Histochemistry. A Laboratory Manual of Current Methods, Oxford: BIOS.
55. Caldero J, Campo E, Vinas J and Cardesa A, 1989, Lectin-binding sites in neoplastic and non-neoplastic colonie mucosa of 1,2-dimethylhydrazine-treated rats. Lab Invest, 61, 670-6.
56. Cox SW and Eley BM, 1987, Preliminary studies on cysteine and serine proteinase activities in inflamed human gingiva using different 7-amino-4-trifluoromethyl coumarin substrates and protease inhibitors. Arch Oral Biol, 32, 599-605.
57. Pagano M, Keppler D, Fumeron-Dalet V and Engler R, 1986, Inhibition of the cathepsin B like proteinase by a low molecular weight cysteine-proteinase inhibitor from ascitic fluid and plasma alpha 2 macroglobulin. Biochem Cell Biol, 64, 1218-25.
58. Yagel S, Warner AH, Nellans HN, Lala PK, Waghorne C and Denhardt DT, 1989, Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells. Cancer Res, 49, 3553-7.
59. Redwood SM, Liu BC, Weiss RE, Hodge DE and Droller MJ, 1992, Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s). Cancer, 69, 1212-19.
60. Navab R, Mort JS and Brodt P, 1997, Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64. Clin Exp Metastasis, 15, 121-9.
61. Fidler IJ, 1991, Cancer metastasis. Br Med Bull, 47, 157-77.
62. Fidler IJ, Wilmanns C, Staroselsky A, Radinsky R, Dong Z and Fan D, 1994, Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Rev, 13, 209-22.
63. Nakajima M, Morikawa K, Fabra A, Bucana CD and Fidler IJ, 1990, Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst, 82, 1890-8.
64. Wheatley AM, Almond NE, Stuart ET and Zhao D, 1993, Interpretation of the laser Doppler flow signal from the liver of the rat. Microvasc Res, 45, 290-301.
65. Richardson FC, Morgan PH, Boucheron JA, Deal FH and Swenberg JA, 1988, Hepatocyte initiation during continuous administration of diethylnitrosamine and 1,2-sym-dimethylhydrazine. Cancer Res, 48, 988-92.
66. Elmore LW and Sirica AE, 1991, Phenotypic characterization of metaplastic intestinal glands and ductular hepatocytes in cholangiofibrotic lesions rapidly induced in the caudate liver lobe of rats treated with furan. Cancer Res, 51, 5752-9.
67. Jones HB, Clarke NAB and Barrass NC, 1993, Phenobarbital-induced hepatocellular proliferation: anti-bromodeoxyuridine and anti-proliferating cell nuclear antigen immunocytochemistry. J Histochem Cytochem, 41, 21-7.
68. Shirai Y, Wakai T, Ohtani T, Sakai Y, Tsukada K and Hatakeyama K, 1996, Colorectal carcinoma metastases to the liver - does primary tumor location affect its lobar distribution. Cancer, 77, 2213-16.
69. Dodds WJ, Erickson SJ, Taylor AJ, Lawson TL and Stewart ET, 1990, Caudate lobe of the liver: anatomy, embryology, and pathology. Am J Roentgenol, 154, 87-93.
70. Barbera-Guillem E, Alonso-Varona A and Vidal-Vanaclocha F, 1989, Selective implantation and growth in rats and mice of experimental liver metastasis in acinar zone one. Cancer Res, 49, 4003-10.
71. Barbera-Guillem E, Rocha M, Alvarez A and Vidal-Vanaclocha F, 1991, Differences in the lectin-binding patterns of the periportal and perivenous endothelial domains in the liver sinusoids. Hepatology, 14, 131-9.
72. Dijkstra CD, Döpp EA, Joling P and Kraal G, 1985, The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology, 54, 589-99.
73. McMaster WR and Williams AF, 1979, Identification of Ia glycoproteins in rat thymus and purification from rat spleen. Eur J Immunol, 9, 426-33.
74. Bouwens L and Wisse E, 1992, Pit cells in the liver. Liver, 12, 3-9.
75. Duijvestijn AM, van Goor H, Klatter F, Majoor GD, van Bussel E and van Breda Vriesman PJ, 1992, Antibodies defining rat endothelial cells: RECA-1, a pan-endothelial cell-specific monoclonal antibody. Lab Invest. 66, 459-66.
76. Robinson AP, White TM and Manson DW, 1986, MRC OX43: a monoclonal antibody which reacts with all vascular endothelium in the rat except that of brain capillaries. Immunology, 57, 231-7.
77. Lamme EN, De Vries HJC, Van Veen H, Gabbiani G, Westerhof W and Middelkoop E, 1996, Extracellular matrix characterization during healing of full-thickness wounds treated with a collagen/elastin dermal substitute shows improved skin regeneration in pigs. J Histochem Cytochem, 44, 1311-22.
78. Christensen L, 1990, Fibronectin: a discrimination marker between small invasive carcinomas and benign proliferative lesions of the breast. Apmis, 98, 615-23.
79. Gulubova MV, 1996, Ultrastructural sinusoidal changes in extrahepatic cholestasis - light and electron microscopic immunohistochemical localization of collagen type III and type IV. Acta Histochem, 98, 271-83.
80. Everts V, Korper W, Niehof A, Jansen D and Beertsen W, 1994, Type VI collagen is phagocytosed by fibroblasts and digested in the lysosomal apparatus: involvement of collagenase, serine proteinases and lysosomal enzymes. Matrix Biol, 14, 665-76.